Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
High-Growth Stocks Come Back Into Investors' Favor
08:18pm, Wednesday, 23'rd Jun 2021
The short-term bottom for next-generation enterprises is in, and high multiple stocks are returning to investors' favor.
10x Genomics: Promising Growth From A Life Science Leading Single Cell Specialist
12:52am, Monday, 31'st May 2021
10x Genomics, Inc. is a global life sciences technology company developing innovative biological products from their cross-functional expertise across biology, chemistry, software, and hardware with a
Here's Why 10x Genomics Can't Satisfy Short-Term Investors
01:06pm, Saturday, 29'th May 2021
Long-term investors should keep perspective.
Strength Seen in 10x Genomics (TXG): Can Its 3.9% Jump Turn into More Strength?
06:01am, Friday, 28'th May 2021
10x Genomics (TXG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Down More Than 20%, Is This Cathie Wood Biotech A Buy?
06:50am, Thursday, 20'th May 2021
10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
Recap: 10x Genomics Q1 Earnings
08:49am, Thursday, 13'th May 2021
Shares of 10x Genomics (NASDAQ:TXG) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 186.96% over the past year to $0.66, which beat the estimate of
Why Investors Didn't Like 10x Genomics' Q1 Results
06:04am, Thursday, 06'th May 2021
The company delivered tremendous revenue growth but a deteriorating bottom line.
10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates
10:10pm, Wednesday, 05'th May 2021
10x Genomics (TXG) delivered earnings and revenue surprises of 56.00% and 2.99%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
10x Genomics, Inc. (TXG) CEO Serge Saxonov on Q1 2021 Results - Earnings Call Transcript
08:48pm, Wednesday, 05'th May 2021
10x Genomics, Inc. (TXG) CEO Serge Saxonov on Q1 2021 Results - Earnings Call Transcript
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
04:05pm, Thursday, 29'th Apr 2021
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare Confe
Earnings Preview: 10x Genomics (TXG) Q1 Earnings Expected to Decline
01:49pm, Wednesday, 28'th Apr 2021
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
06:35am, Saturday, 24'th Apr 2021
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
3 Hot Healthcare Stocks Cathie Wood Is Buying in April
06:01am, Saturday, 17'th Apr 2021
Here's why she likes them so much.
How 10x Genomics Is Turbocharging Genetic Research
06:04am, Tuesday, 06'th Apr 2021
The company's technology is enabling researchers to explore single cells like never before.
How Genomics Research Could Change How Multiple Sclerosis Is Treated
07:05am, Monday, 05'th Apr 2021
10x Genomics CEO Serge Saxonov thinks we're at the threshold of some big discoveries.
